Roche and UCB partner to develop antibody therapy for Alzheimer’s
Roche and its unit Genentech have agreed to a global, exclusive licence agreement with Belgian...
UCB acquires Engage Therapeutics for $125m
Belgian biopharmaceutical firm UCB has acquired US-based pharmaceutical company Engage Therapeutics for a cash consideration...
Univercells’ Cell and Gene Therapy Manufacturing Facility, Jumet, Belgium
Univercells is developing a facility in Jumet, Belgium for the production of cell and gene...
Orionis and Novartis enter drug discovery deal
Life sciences firm Orionis Biosciences has partnered with Novartis to discover and design new drugs...
Galapagos expands fibrosis research collaboration with Fibrocor
Galapagos has expanded its research collaboration with Candian firm Fibrocor Therapeutics, which develops tissue-specific therapeutics...
Promethera closes Series D funding round to support expansion
Cell-based drugs developer Promethera Biosciences has closed a Series D financing round to support its...
Newpharma collaborates with Ingenico for e-payments
Belgian online pharmacy firm Newpharma has partnered with UK-based payments company Ingenico Group to enable...
UCB acquires Ra Pharma for $2.1bn to enrich its rare disease portfolio
UCB has acquired Massachusetts-based Ra Pharmaceuticals for $48 per share, bringing the total transaction to...
UCB to acquire Ra Pharmaceuticals in $2.1bn deal
Belgian biopharmaceutical firm UCB has signed a merger agreement to acquire US-based Ra Pharmaceuticals for...
Gilead and Galapagos deal: building on filgotinib agreement
US-based Gilead has entered into a ten-year global research and development (R&D) collaboration agreement with...